Intrommune Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Intrommune Therapeutics's estimated annual revenue is currently $2.8M per year.
- Intrommune Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Intrommune Therapeutics has 18 Employees.
- Intrommune Therapeutics grew their employee count by -10% last year.
Intrommune Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and CSO | Reveal Email/Phone |
2 | Founder & CEO | Reveal Email/Phone |
3 | Chief Regulatory Officer | Reveal Email/Phone |
4 | Operations Manager | Reveal Email/Phone |
5 | Manager, Administration & Social Media | Reveal Email/Phone |
Intrommune Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Intrommune Therapeutics?
Intrommune Therapeutics is a specialty biopharmaceutical company located in New York, NY. Intrommune is developing a revolutionary new treatment platform for food allergies that is safe, effective and convenient. Intrommune's first product is a therapy for patients who suffer from peanut allergy. Intrommune is developing the oral mucosal immunotherapy (OMIT) platform for food allergies. It is a long-term solution for the 220 million, including 9 million U.S. adults and 6 million U.S. children, who suffer from this life-altering condition.
keywords:N/AN/A
Total Funding
18
Number of Employees
$2.8M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Intrommune Therapeutics News
Intrommune Expands Study Scope to Explore MTD. NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a New York-based,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 18 | 13% | N/A |
#2 | $0.8M | 18 | 64% | $68.7M |
#3 | $1.6M | 18 | -10% | N/A |
#4 | $2.2M | 18 | -5% | N/A |
#5 | $233.2M | 18 | 6% | $3.2M |